awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38340949-CE088F6E-1C1C-43FC-9C23-7B66F68B99D9
Q38340949-CE088F6E-1C1C-43FC-9C23-7B66F68B99D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38340949-CE088F6E-1C1C-43FC-9C23-7B66F68B99D9
Ipragliflozin , a sodium-glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetes.
P2860
Q38340949-CE088F6E-1C1C-43FC-9C23-7B66F68B99D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38340949-CE088F6E-1C1C-43FC-9C23-7B66F68B99D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10ce0dbf38b6861df3cda550629b03423e862656
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus